🔗 Share this article Prestigious Prize Recognizes Pioneering Immune System Research The Nobel Prize in Physiology or Medicine was granted for transformative discoveries that clarify how the body's defense network attacks dangerous infections while sparing the healthy tissues. Three renowned scientists—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this accolade. Their work identified unique "security guards" within the defense system that eliminate rogue defense cells capable of harming the body. The discoveries are now enabling innovative therapies for autoimmune diseases and malignancies. These winners will divide a monetary award valued at 11m SEK. Crucial Discoveries "The work has been essential for comprehending how the immune system operates and why we do not all develop severe autoimmune diseases," stated the head of the Nobel Committee. This team's research address a fundamental mystery: In what way does the defense system protect us from countless infections while leaving our own tissues unharmed? The immune system employs white blood cells that search for indicators of disease, including viruses and germs it has never encountered. These cells utilize sensors—called recognition units—that are generated by chance in a vast number of combinations. This provides the defense network the ability to fight a wide array of threats, but the unpredictability of the process unavoidably creates white blood cells that can attack the body. Security Guards of the Body Scientists previously understood that some of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature. The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "security guards"—which travel through the body to disarm any immune cells that assault the healthy cells. It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA. A Nobel panel stated, "The discoveries have established a new field of investigation and accelerated the development of new treatments, for instance for tumors and immune disorders." In malignancies, T-regs block the body from attacking the tumor, so research are aimed at lowering their numbers. For autoimmune diseases, trials are testing boosting regulatory T-cells so the organism is no longer being harmed. A similar method could also be effective in reducing the risks of organ transplant failure. Pioneering Experiments Prof Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, causing autoimmune disease. He demonstrated that injecting defense cells from healthy animals could stop the illness—implying there was a mechanism for preventing immune cells from harming the body. Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and humans that resulted in the identification of a gene critical for how T-regs function. "The pioneering research has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology expert. "This research is a remarkable illustration of how basic physiological study can have broad implications for human health."